Previous Close | 21.60 |
Open | 21.60 |
Bid | 21.80 x N/A |
Ask | 22.60 x N/A |
Day's Range | 21.60 - 22.00 |
52 Week Range | 16.20 - 29.00 |
Volume | |
Avg. Volume | 11 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Mar 07, 2023 - Mar 13, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for 08D.DU
FOSTER CITY, Calif., January 11, 2023--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif., January 09, 2023--Mirum Pharmaceuticals Announces Preliminary Unaudited LIVMARLI 2022 Net Revenue and Provides Corporate Updates
FOSTER CITY, Calif., January 03, 2023--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will present at the annual J.P. Morgan Healthcare Conference taking place January 9-12, 2023.